bf/NASDAQ:INM_icon.png

NASDAQ:INM

InMed Pharmaceuticals Inc.

  • Stock

USD

Last Close

0.29

20/05 20:00

Market Cap

2.41M

Beta: 1.06

Volume Today

38.72K

Avg: 631.00K

PE Ratio

−0.16

PFCF: −0.24

Jun '13
Jun '14
Jun '15
Jun '16
Jun '17
Jun '18
Jun '19
Jun '20
Jun '21
Jun '22
Jun '23
revenue
1.09M
-
4.14M
279.61%
cost of revenue
92.78K
-
93.94K
1.25%
183.09K
94.90%
197.03K
7.61%
545.89K
177.06%
2.73M
400.56%
gross profit
-92.78K
-
-93.94K
1.25%
-183.09K
94.90%
-197.03K
7.61%
543.55K
375.87%
1.40M
158.13%
selling and marketing expenses
22.65K
-
498.44K
2,100.50%
112.64K
77.40%
844.27K
649.53%
706.23K
-
474.94K
32.75%
general and administrative expenses
46.75K
-
1.09M
2,240.98%
2.62M
139.48%
1.48M
43.64%
2.79M
88.93%
6.00M
-
3.50M
41.63%
4.48M
27.84%
6.87M
53.30%
5.85M
14.85%
selling general and administrative expenses
46.75K
-
1.09M
2,240.98%
2.62M
139.48%
1.48M
43.64%
2.79M
88.93%
5.17M
85.19%
6.00M
16.16%
3.50M
41.63%
4.48M
27.84%
6.87M
53.30%
5.85M
14.85%
research and development expenses
57.87K
-
759.85K
1,212.97%
292.84K
61.46%
573.72K
95.92%
1.52M
164.45%
4.30M
183.09%
5.20M
21.12%
5.34M
2.62%
7.28M
36.43%
3.73M
48.75%
other expenses
-900.75
-
75.76K
8,510.45%
67.41K
11.02%
75.22K
11.58%
-0.00
100.00%
94.72K
40,680,212,240,793,696%
161.97K
71.00%
120.87K
25.38%
185.66K
53.61%
-308.94K
266.40%
cost and expenses
46.75K
-
1.15M
2,362.85%
3.46M
200.21%
1.84M
46.84%
3.44M
87.21%
6.78M
97.06%
10.39M
53.33%
8.87M
14.67%
9.94M
12.07%
14.88M
49.74%
12.51M
15.90%
operating expenses
46.75K
-
1.15M
2,362.85%
3.46M
200.21%
1.84M
46.84%
3.44M
87.21%
6.69M
94.36%
10.39M
55.46%
8.87M
14.67%
9.94M
12.07%
14.34M
44.24%
9.78M
31.76%
interest expense
10.45
-
1.69K
16,091.50%
3.53K
108.26%
47.92
98.64%
495.17
933.29%
18.62K
-
360.35K
1,835.70%
96.09K
73.33%
ebitda
-46.75K
-
-1.15M
2,360.95%
-3.38M
193.70%
-1.77M
47.62%
-3.36M
90.07%
-6.69M
98.72%
-10.26M
53.53%
-8.58M
16.41%
-9.80M
14.24%
-13.18M
34.51%
-7.73M
41.33%
operating income
-49.19K
-
-1.15M
2,239.04%
-3.45M
200.28%
-1.84M
46.81%
-3.44M
87.19%
-6.78M
97.07%
-10.36M
52.83%
-8.74M
15.61%
-9.92M
13.50%
-13.70M
38.03%
-8.18B
59,601.65%
depreciation and amortization
2.44K
-
40.30
98.35%
75.76K
187,863.85%
67.41K
11.02%
75.22K
11.58%
92.78K
23.35%
94.72K
2.09%
161.97K
71.00%
120.87K
25.38%
511.79K
323.43%
596.00K
16.45%
total other income expenses net
2.45K
-
-846.39
134.56%
-1.76K
108.26%
-23.96
98.64%
-247.59
933.29%
230.00
192.90%
262.10K
113,856.96%
60.73K
76.83%
-280.82K
562.39%
-4.90M
1,646.46%
-48.17K
99.02%
income before tax
-46.74K
-
-1.15M
2,365.21%
-3.46M
200.14%
-1.84M
46.87%
-3.44M
87.22%
-6.71M
95.01%
-10.10M
50.51%
-8.68M
14.02%
-10.20M
17.53%
-18.60M
82.30%
-7.93M
57.34%
income tax expense
-2.46K
-
1.69K
168.83%
3.53K
108.26%
47.92
98.64%
495.17
933.29%
-69.54K
14,144.03%
-262.10K
276.90%
18.62K
107.10%
360.35K
1,835.70%
4.81M
1,234.36%
13.10K
99.73%
net income
-46.74K
-
-1.15M
2,365.21%
-3.46M
200.14%
-1.84M
46.87%
-3.44M
87.22%
-6.71M
95.01%
-9.83M
46.60%
-8.70M
11.54%
-10.56M
21.42%
-23.41M
121.60%
-7.95M
66.05%
weighted average shs out
40.84K
-
41.93K
2.69%
55.87K
33.24%
72.97K
30.59%
108.43K
48.60%
172.67K
59.25%
207.09K
19.94%
208.83K
0.84%
268.79K
28.72%
560.75K
108.62%
2.45M
336.10%
weighted average shs out dil
40.84K
-
41.93K
2.69%
55.87K
33.24%
72.97K
30.59%
108.43K
48.60%
172.67K
59.25%
207.09K
19.94%
208.83K
0.84%
268.79K
28.72%
560.83K
108.65%
2.45M
336.58%
eps
-1.20
-
-29.31
2,342.50%
-76.83
162.13%
-32.58
57.59%
-41.26
26.64%
-38.85
5.84%
-47.49
22.24%
-41.66
12.28%
-39.30
5.66%
-41.74
6.21%
-3.25
92.21%
epsdiluted
-1.20
-
-29.31
2,342.50%
-76.83
162.13%
-32.58
57.59%
-41.26
26.64%
-38.85
5.84%
-47.49
22.24%
-41.66
12.28%
-39.30
5.66%
-41.74
6.21%
-3.25
92.21%

All numbers in USD (except ratios and percentages)